SCHEMBL15499181

SCHEMBL15499181

CCOc1cccc(/C=C/c2ccc(N(c3ccc(-c4ccc(N(c5ccc(/C=C/c6cccc(OCC)c6)cc5)c5c(C)cc(C)cc5C)cc4)cc3)c3c(C)cc(C)cc3C)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RELA Q04206 3/20 0.44
LCK P06239 1/20 0.41
ESR1 P03372 2/20 0.41
AHR P35869 1/20 0.41
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CYP19A1 P11511 1/20 0.38
CHRNA7 P36544 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15496823 0.96 RELA (0.45) KDM4EALDH1A1SMN1; SMN2RELALCK
SCHEMBL15496816 0.85 RELA (0.61) RELAESR1NFE2L2CYP19A1CHRNA7
SCHEMBL12376974 0.84 KDM4E (0.52) KDM4EALDH1A1SMN1; SMN2RELALCK
SCHEMBL15496879 0.81 RELA (0.49) KDM4EALDH1A1SMN1; SMN2RELAMEN1
SCHEMBL4407606 0.79 NFE2L2 (0.51) RELANFE2L2CTDSP1
SCHEMBL14727240 0.78 PTGS1 (0.44) KDM4ERELAMEN1NPC1MAPT
SCHEMBL12128432 0.78 PTGS1 (0.39) SMN1; SMN2RELAMEN1NPC1MAPT
SCHEMBL15499123 0.78 MAPT (0.41) KDM4EALDH1A1SMN1; SMN2RELAESR1
SCHEMBL12565444 0.77 RXRA (0.41) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL15496820 0.76 RAB9A (0.39) KDM4EALDH1A1SMN1; SMN2RELAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9709906-B2 Charge transport substance, electrophotographic photoreceptor, electrophotographic photoreceptor cartridge, and image-forming apparatus MITSUBISHI CHEMICAL CORPORATION (JP) 2017-07-18 US disclosed
US-20150355559-A1 CHARGE TRANSPORT SUBSTANCE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE-FORMING APPARATUS MITSUBISHI CHEMICAL CORPORATION (JP) 2015-12-10 US disclosed
US-20140065532-A1 CHARGE TRANSPORT SUBSTANCE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE-FORMING APPARATUS MITSUBISHI CHEMICAL CORPORATION (JP) 2014-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150355559-A1 CHARGE TRANSPORT SUBSTANCE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE-FORMING APPARATUS PDE6C, SLC18A2, SLC1A2 KDM4E 4730/4885ALDH1A1 1118/4885SMN1; SMN2 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.